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ABSTRACT Human ceruloplasmin (CP) is a multicopper oxidase essential for normal iron homeostasis. The protein has six
domains with one type-1 copper in each of domains 2, 4, and 6; the remaining coppers form a catalytic trinuclear cluster at the
interface between domains 1 and 6. To assess the role of the coppers inCP thermal stability, we have probed the thermal unfolding
process as a function of scan rate of holo- and apo-forms using several detection methods (circular dichroism, aromatic and
8-anilino-naphthalene-1-sulfonic acid ﬂuorescence, visible absorption, activity, and differential scanning calorimetry). Both spe-
cies ofCPundergo irreversible thermal reactions to denatured stateswith signiﬁcant residual structure. For identical scan rates, the
thermal midpoint appears at temperatures 15–20 higher for the holo- as compared with the apo- form. The thermal data for both
formswere ﬁt by amechanistic model involving two consecutive, irreversible steps (N/ I/D). The holo-intermediate, I, has lost
oneoxidized type-1 copper and secondary structure in at least onedomain; however, the trinuclear copper cluster remains intact as
it is functional in oxidase activity. The activation parameters obtained from the ﬁts to the thermal transitionswere used to assess the
kinetic stability of apo- and holo-CP at physiological temperatures (i.e., at 37C). It emerges that native CP (i.e., with six coppers) is
rather unstable and converts to I in,1 day at 37C.Nonetheless, this form remains intact formore than 2weeks andmay thus be a
biologically relevant state of CP in vivo. In contrast, apo-CP unfolds rapidly: the denatured state is reached in,2 days at 37C.
INTRODUCTION
Ceruloplasmin (CP; EC 1.16.3.1) is a multicopper protein
widely distributed in vertebrates. It occurs mainly in the plasma
and plays an important role in iron homeostasis (1,2). Other
roles include its participation in the antioxidant defense (3–6)
or in oxidative damage mechanisms (7,8) and its involvement
in a number of processes related to the metabolism of copper
(9), biogenic amines (10), and nitric oxide (11).
Human ceruloplasmin is a single chain of 1046 amino acids
(12) with a carbohydrate content of 7–8% and six integral
copper ions. The x-ray structure has shown that CP is com-
posed of six compact b-barrel domains with large loop in-
sertions and that the six copper ions are distributed in one
trinuclear copper cluster (involving type-2 and type-3 copper
ions) located at the border between domains 1 and 6 and
possessing ligands from each domain, and in three mononu-
clear type-1, or ‘‘blue’’, sites (13). The mononuclear copper
sites located in domains 4 and 6 of CP are typical type-1 sites,
like that in ascorbate oxidase (14), and have four ligands (two
histidines, one cysteine, and one methionine) arranged in a
distorted tetrahedral geometry. The type-1 copper site located
in domain 2 is instead a tricoordinated type-1 site in that it
lacks an axial Met ligand. This position is replaced by Leu in
CP, like blue-copper sites in some laccases (15), and in Fet3
(16). The type-1 copper in domain 2 has been found to be
permanently reduced and is not involved in catalytic activity
(17,18). CP is synthesized in hepatocytes and secreted into the
plasma after incorporation of six copper ions in the secretory
pathway (19). Failure to incorporate copper during biosyn-
thesis results in the secretion of an unstable polypeptide that is
rapidly degraded in the plasma (20). In Wilson’s disease, the
absence or impaired function of a copper-transporting ATPase
disrupts copper translocations into the secretary pathway,
resulting in decreased serum levels of CP in affected patients
(21). Aceruloplasminemia, an autosomal recessive neurode-
generative disease, is associated with mutations in the CP gene
and accompanied by absence of CP oxidase activity (22).
Previous studies have indicated that the conformation of
apo-CP is different from that of the holoprotein (23,24). It was
proposed that the apo- form has molten-globule-like proper-
ties, although a significant amount of residual tertiary struc-
ture remained (23). For more than 40 years, the working model
has assumed that CP binds copper in an all-or-none fashion
(25). In support, recent metabolic labeling experiments indi-
cated that achieving the final state of CP required occupation
of all six copper-binding sites, with no apparent hierarchy for
incorporation at any given site (19). On the other hand, there
have also been a number of reports that invoke the possibility
of partially metalated forms of CP (26,27). Based on cyanide-
dependent metal-removal attempts, it was suggested that the
type-1 coppers are more sensitive than the type-2 and type-3
coppers to elimination (27,28). Very recently, we showed that
chemically induced equilibrium denaturation of CP at room
temperature proceeds through an intermediate (I) that has lost
two copper ions (29). Whereas the I forms reversibly, complete
unfolding and loss of all copper ions result in an irreversibly
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denatured state. Attempts to refold this species at pH 7 result
in the formation of a misfolded molten globule, regardless of
the presence or absence of copper ions (29).
To analyze the role of copper in thermal stability, we have
investigated the thermal denaturation reactions of holo- and
apo- forms of human CP by circular dichroism (CD), fluores-
cence, visible absorption, oxidase activity, and differential
scanning calorimetry (DSC) methods. The thermal reactions
were analyzed according to Lyubarev and Kurganov’s model
(30) for two consecutive irreversible steps. The data reveal
the presence of a partially folded intermediate, with (for the
holo- form) an intact trinuclear site but loss of one or two
type-I coppers at intermediate temperatures. The activation
parameters extracted from fits to thermal transitions at dif-
ferent scan rates were used to predict the kinetic behavior of
CP at 37C (pH 7). It emerges that the native, six-copper form
of CP is rather unstable at this temperature (half-life of 14 h),
whereas the intermediate form remains intact for weeks; the
latter species may therefore be present during in vivo CP
circulation.
EXPERIMENTAL PROCEDURES
Chemicals and instruments
Analytical-grade chemicals and o-dianisidine were obtained from Sigma-
Aldrich (St. Louis, MO). 2,29- Biquinoline was obtained from Fluka (Seelze,
Germany). Human CP (.95% purity, A610/A280 ¼ 0.046) was obtained
from Vital Products (Boynton Beach, FL). Concentration of holo- and apo-
CP was determined by e280nm of 200 mM
1cm1. Absorbance and far-UV
CD measurements were performed on Varian Cary 50 and Jasco J-810 spec-
trometers, respectively.
Copper removal
To prepare apo-CP, 5 mg/ml of CP was dialyzed for 2 h at 4C against 50
mM ascorbate in 0.1 M TrisHCl, pH 7.2. Subsequently, dialysis continued
for 12–14 h at 4C against 50 mM NaCN, 10 mM EDTA, and 10 mM ascor-
bate in 0.1 M TrisHCl, pH 7.2. The dialysis proceeded for another 16 h at
4C (with buffer exchange after 8 h) against 50 mM sodium phosphate buffer,
pH 7.0. The final apo- form of CP prepared this way contained 0.6 6 0.4
coppers/CP, as determined by the method developed by Felsenfeld (31).
Activity assay
Oxidase activity of CP was tested using o-dianisidine as a substrate in
accordance with the procedure by Schosinsky et al. (32). CP activity as a
function of temperature was determined as follows: a sample with CP was
heated at a rate of 1 K/min; after the desired temperature was reached, a
25-ml aliquot of CP solution was transferred into 100 ml 100 mM acetate,
pH 5.0, and cooled on ice. The activity was measured at 23C.
DSC
DSC experiments were performed on a VP-DSC differential scanning micro-
calorimeter (Microcal, Northampton, MA) at scan rate of 1.0 K/min. Protein
concentration was 3–4 mM (pH 7). Before measurements, sample and refer-
ence solutions were properly degassed in an evacuated chamber for 5 min at
room temperature and carefully loaded into the cells to avoid bubble forma-
tion. Exhaustive cleaning of the cells was undertaken before each experi-
ment. A pressure of 2 atm was kept in the cells throughout the heating cycles
to prevent degassing. A background scan collected with buffer in both cells
was subtracted from each scan. The reversibility of the transitions was as-
sessed by the reproducibility of the calorimetric trace in a second heating
cycle performed immediately after cooling from the first scan. Excess heat
capacity curves were plotted using Origin software supplied by Microcal.
CD
CD spectra in the far-UV range (190–250 nm) were recorded on a Jasco-810
instrument with cell path of 1 mm and protein concentrations of 0.3–0.4 mM.
Each spectrum is an average of 10 scans. All spectra were background-corrected
and converted to mean residue ellipticity (degcm2/dmol). The thermal CD
experiments were monitored at 210 nm using a constant heating rate of
0.5, 1, or 1.5 K/min in separate experiments.
Fluorescence
Samples of the holo- or apo- form (;3 mM) of CP were mixed with 200 mM
8-anilino-naphthalene-1-sulfonic acid (ANS) and incubated for 1 h at 23C.
The sample temperature was increased at a constant scan rate (0.5, 1, or 1.5
K/min in separate experiments). The same sample was monitored both for
tryptophan and ANS fluorescence at 335 nm (excitation at 295 nm) and 510
nm (excitation at 390 nm), respectively.
Data analysis
DSC-, fluorescence-, and CD-monitored thermal transitions were analyzed
according to the model by Lyubarev and Kurganov involving two consecu-
tive irreversible steps of reaction:
N !k1 I !k2 D; (1)
where N, I, and D are native, partially denatured, and denatured states,
respectively, and k1 and k2 are rate constants of corresponding reactions (30).
This model is described by a set of differential equations (see Results). Dif-
ferential equations were solved numerically, and the sum of squared differ-
ences between experimental and generated points was minimized. Standard
deviations were calculated using 10 sets of the generated data with added
Gaussian white noise. Distribution moments of the noise were modeled
according to the resulting distribution of the residuals. The correlation coef-
ficient (R) was calculated as:
R ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1  +
n
i¼1
ðyi  ycalci Þ2=+
n
i¼1
ðyi  ymi Þ2
s
; (2)
where yi and y
calc
i are, respectively, the experimental and calculated values of
Cexp ; y
m
i is the mean of the experimental values of C
ex
p and n is the number of
points (e.g., (33)).
Time dependence of the mole fractions gN, gI, and gD of the three
different forms of CP (N, I, and D) at 37C were obtained from the following
analytical equations:
gN ¼ expðk1tÞ (3)
gI ¼
k1
k2  k1½expðk1tÞ  expðk2tÞ (4)
gD ¼ 11
1
k1  k2½k2 expðk1tÞ  k1expðk2tÞ; (5)
where the rate constants at any given temperature can be obtained from the
Arrhenius equation, k ¼ AexpðEa=RTÞ; where A is the preexponential fac-
tor, Ea is the energy of activation, and R is the gas constant. It is convenient
to use an alternative form of the Arrhenius equation where the parameter
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T* (temperature at which rate constant equals 1 min1) is used instead of the
parameter A:
k ¼ exp½Ea=Rð1=T  1=TÞ: (6)
RESULTS
Thermal denaturation of CP monitored by
far-UV CD
Thermal denaturation of holo- (i.e., six copper) and apo- (i.e.,
no copper) forms of CP was first monitored by far-UV CD.
These experiments show that 1), the thermal transitions of
both apo- and holo- forms of CP are irreversible, and 2), they
proceed to a state characterized by significant negative ellip-
ticity in the 200- to 210-nm range (Fig. 1). The latter finding
indicates that there is residual structure in the thermally dena-
tured state of both apo- and holo-forms. In contrast, chemi-
cally denatured CP (at 20C) has much less negative ellipticity
(29), and the far-UV CD spectrum instead matches that of an
unfolded protein (Fig. 1). The irreversibility of the thermal
transition is not caused by protein aggregation because no
signs of aggregation or precipitation were observed. The ther-
mal denaturation processes for both holo- and apo- forms of
CP depend on the heating rate: the faster the rate, the higher
the apparent thermal midpoint (Fig. 2). Comparing thermal
curves at identical scan rates (three different scan rates tested)
reveals that the holo- form of CP is more resistant to thermal
perturbation than the apo-form by ;15–20C.
Thermal denaturation of CP monitored by DSC
To obtain more insight into thermal denaturation of CP we
next turned to DSC experiments. In Fig. 2, we show DSC data
as a function of temperature for both forms of CP at three
different scan rates. We note that the transitions observed by
CD and DSC at the same scan rate correspond well with each
other. The DSC scans clearly demonstrate that the thermal
transitions for both forms include at least two steps. From
various cooling experiments, we found (as in the CD experi-
ments) that both transitions appear irreversible under our con-
ditions.
Two consecutive irreversible transitions can be described
by Eq. 1 in Materials section: N !k1 I !k2 D.
This model can be considered a particular case of the Lumry-
Eyring model in which the rate of the reverse reaction of the
first step is much slower than the rate of the second step (34).
Analysis of DSC data using the model of two consecutive
irreversible steps has been described in detail by Lyubarev
and Kurganov (30). Briefly, the kinetic behavior of the
system is described by the following differential equations:
dgN
dt
¼ k1gN (7a)
dgI
dt
¼ k1gN  k2gI (7b)
where gN and gI are the mole fractions of native and partially
unfolded protein, respectively. After substituting dt ¼ dT/n,
where n is the scan rate, and solving the equations, the fol-
lowing is obtained:
gN ¼ expð
1
v
Z T
T0
k1dTÞ: (8)
gI ¼
1
v
expð1
v
Z T
T0
k2dTÞ
Z T
T0
k1exp
1
v
Z T
T0
ðk2  k1ÞdT
  
dT:
(9)
The excess heat capacity, which is the parameter measured in
the DSC experiments, is then expressed by the equation:
C
ex
p ¼
dÆDHæ
dT
¼ DH1k1
v
gN1
DH2k2
v
gI; (10)
where DH1 and DH2 are molar enthalpy changes for the first
and second steps, respectively. The rate constants, k, are re-
lated toEa and T* via Eq. 6. The DSC data in Fig. 2 were fitted
to Eq. 10, and the resulting six parameters (DH1, DH2, Ea1,
Ea2, T1*, and T2*) are listed in Table 1.
In analogy, the temperature dependences of the CD and
fluorescence signals were fitted by the following equation:
Sobs ¼ SNgN1 SIgI1 SDð1  gN  gIÞ; (11)
where Sobs, SN, SI, and SD are measured signal and signals of
native, partially denatured, and denatured states, respectively.
In combination with the expressions for each mole fraction
given in the equations above (using CD signals instead of en-
thalpy changes), and the relation among k, Ea, and T* pro-
vided by Eq. 6, the key parameters (i.e., Ea and T* values)
could be obtained from fits to the CD-detected profiles (Table 1).
The parameters for the first transition (N to I) obtained from
CD differ somewhat from those obtained from DSC. This is
likely an effect of the poor separation of the two thermal steps
when probed by CD, causing unreliable fits. The theoretical
FIGURE 1 CD spectra of N (thick lines, at 20C, pH 7.0) and D (thin line,
at 70C, pH 7.0) forms of holo-CP (solid lines) and apo-CP (dotted lines).
For comparison, GuHCl-perturbed CP (at 20C, pH 7.0) is also shown
(dash-dot line). CD spectra of 3Cu-CP N and D forms are indistinguishable
of those of holo-CP.
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DSC and CD curves based on the fitted parameters are shown
in Fig. 2 and are in good agreement with the actual data. This
supports the two-step irreversible mechanism as an appropri-
ate assumption.
Thermal denaturation of CP monitored by
other methods
To further investigate the thermal reactions of CP, tryptophan
fluorescence and fluorescence of ANS were probed as a func-
tion of temperature. CP has 19 tryptophans that are scattered
throughout the six domains. Normalized tryptophan and ANS
fluorescence signals of apo- and holo- forms of CP as a func-
tion of temperature are shown in Fig. 3 for three different scan
rates. Whereas the data for apo-CP adopt an asymmetrical
sigmoidal shape (Fig. 3 A), holo-CP fluorescence data clearly
show three-state behavior (Fig. 3 B). For both holo- and apo-
forms, the tryptophan-emission changes as a function of tem-
perature were not affected by the presence or absence of ANS.
Thus, ANS in itself did not have any effect on CP thermal
FIGURE 2 Thermal transitions of apo- (A and C) and
holo- (B and D) forms of CP monitored by CD and DSC.
Ellipticity dependence monitored at 210 nm is shown as
normalized ellipticity. Measurements were performed at
three different scan rates (from left: 0.5, 1.0, and 1.5 K/min)
at pH 7.0. DSC scans were performed at three different scan
rates (from left: 0.5, 1.0, and 1.5 K/min) at pH 7.0. Experi-
mental data are shown as points; theoretical fits based on
Eqs. 10 and 11 are shown as solid lines.
TABLE 1 Calculated parameters based on two-step analysis of the data shown in Figs. 2 and 3 describing the irreversible
thermal transitions of holo- and apo- forms of human CP
CP form Ea1 (kJ/mol) T*1 (K) DH1 (kJ/mol) Ea2 (kJ/mol) T*2 (K) DH2 (kJ/mol) R Tobs
y (C)
Apo 1st/2nd
DSC 0.5 K/min 222 332 407 275 334 1571 0.9980 50.9/55.5
DSC 1.0 K/min 273 328 365 326 333 1593 0.9975 52.7/57.0
DSC 1.5 K/min 267 330 394 323 333 1401 0.9994 53.9/58.0
Average 254 330 389 308 333 1521
FTrp 0.5 K/min 238 334 – 240 334 – 0.9999 54.1
FTrp 1.0 K/min 274 334 – 331 335 – 0.9997 55.6
FTrp 1.5 K/min 239 334 – 322 331 – 0.9999 56.6
CD 0.5 K/min 181 341 – 176 335 – 0.9991 55.3
CD 1.0 K/min 167 341 – 298 332 – 0.9985 57.9
CD 1.5 K/min 187 340 – 265 332 – 0.9979 59.9
Holo
DSC 0.5 K/min 268 334 420 219 353 1917 0.9934 55.0/ 71.6
DSC 1.0 K/min 219 335 443 230 351 1801 0.9989 56.5/ 72.4
DSC 1.5 K/min 275 333 381 232 351 1930 0.9990 57.4/ 74.0
Average 254 334 415 227 351 1883
FTrp 0.5 K/min 275 334 – 175 358 – 0.9996 54.1/ 70.0
FTrp 1.0 K/min 278 333 – 213 354 – 0.9998 56.4/ 72.6
FTrp 1.5 K/min 232 336 – 221 355 – 0.9998 58.5/ 75.9
CD 0.5 K/min 174 347 – 210 357 – 0.9995 56.7/ 71.1
CD 1.0 K/min 152 348 – 235 354 – 0.9986 59.0/ 73.1
CD 1.5 K/min 118 354 – 337 352 – 0.9987 61.6/ 75.0
T* values are the temperatures at which the rate constant for the specific reaction is 1/min. Index 1 corresponds to the first N-to-I transition, and index 2
corresponds to the subsequent I-to-D process. The DSC data are most reliable and were used to derive average values for each parameter. R is the correlation
coefficient (see Eq. 4).
yObserved thermal midpoints; for some apo-CP data, only the midpoint of the major transition is reported.
Kinetic Stability of Ceruloplasmin 1387
Biophysical Journal 94(4) 1384–1391
stability. The obtained parameters from fits to the tryptophan
fluorescence, again assuming a two-step, irreversible reaction
mechanism, are in good agreement with the parameters ob-
tained from the DSC data (Table 1). The ANS emission in-
creases on CP denaturation, with the I species having an
intermediate-sized signal. This implies that I is not a partially
folded molten-globule-like species, as such structures tend to
bind ANS strongly, causing orders of magnitude higher ANS
emission. (The ANS emission data were not analyzed further
because of the nonlinearity of the posttransition regions.)
For holo-CP, 610-nm absorbance was also investigated as
a function of temperature (Fig. 4). Absorbance at 610 nm
monitors the two oxidized type-1 copper sites in CP, i.e., the
coppers in domains 4 and 6. The high reduction potential of
the type-1 copper in domain 2 has indicated that it is perma-
nently reduced; thus, it does not contribute to the blue color,
nor is it catalytically relevant (17,18). We find that 610-nm
absorption of holo-CP decreases gradually with temperature
up to ;60C, where it adopts a signal that is ;50% of its
original value at 20C. At higher temperatures, the remaining
visible absorption rapidly decreases toward zero. This result
indicates perturbation (and likely metal dissociation) of the
two type-1 copper sites in two phases as a function of temper-
ature; one copper goes in the first step, the other in the second
step. The first phase correlates with the formation of the N-to-I
step as detected by CD, fluorescence, and DSC; the second
phase correlates with the I-to-D step detected by the other
methods.
Also CP’s oxidase activity parameters were obtained as a func-
tion of temperature (Fig. 4). Aromatic diamine (o-dianisidine)
oxidation by CP requires an intact trinuclear copper site,
which is situated on the interface between domains 1 and 6.
The type-1 copper site in domain 4 is likely the entry point of
the electrons from this substrate before transfer to the catalytic
cluster (10). When CP solutions heated to different tempera-
tures were cooled to 23C and oxidase activity was measured,
native-like activity was found for samples heated to temper-
atures up to 60C. This indicates that the structural changes of
the first phase (N to I) include distortion of parts of the protein
not involved in catalytic activity. Further increase in temper-
ature leads to irreversible inhibition of CP oxidase activity
with an apparent transition midpoint at 68C. This process
correlates with the second step (i.e., I to D) observed by DSC
and the spectral methods. Based on these results, we conclude
that the trinuclear site is destroyed in the I-to-D step.
DISCUSSION
Human CP is a key protein in copper/iron metabolism (35,36).
It is linked to diseases such as aceruloplasminemia and Wilson’s
disease. From a biophysical point, it is an intriguing, complex
protein with six integral coppers distributed in a structure of
six b-sandwich domains. We recently reported chemical un-
folding data on apo- and holo- forms of human CP. We found
that urea-induced unfolding involves an intermediate with
loss of about two type-1 coppers (one being the permanently
reduced one in domain 2). Complete unfolding was irrevers-
ible because attempts to refold from this starting point resulted
in a dead-end molten globule species (29). Less is known
about CP thermal unfolding. Thermal denaturation of sheep
CP was reported to be irreversible and to have a Ttrs of.70C
(37). However, for irreversible reactions, a high melting
temperature does not guarantee that a protein will remain in
its native state for a given time at a certain temperature (38).
In such cases, information about the structural integrity of
proteins can only be obtained from kinetic parameters. The
physical basis of protein kinetic stability is, however, poorly
understood, and no structural consensus has been found to
explain this phenomenon (39).
FIGURE 3 Thermal transitions of apo- (A) and holo- (B) forms of CP
monitored by tryptophan fluorescence (emission wavelength 335 nm) and
ANS fluorescence (emission wavelength 510 nm). Fluorescence is shown as
normalized ellipticity. Measurements were performed at three different scan
rates (from left: 0.5, 1.0, and 1.5 K/min) at pH 7.0. Experimental data are
shown as points; theoretical fits based on Eq. 11 are shown as solid lines.
FIGURE 4 Thermal dependence of absorbance of holo-CP at 610 nm (s)
and oxidase activity at 20C (d) after heating to the indicated temperatures.
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In this study, we assessed the thermal reaction of human CP
in its apo- and copper-loaded forms to reveal details about ki-
netic stability and specific roles of the coppers. Previously,
copper has been found to add to both equilibrium and kinetic
stability of some proteins (i.e., azurin, ascorbate oxidase, Cu, Zn-
superoxide dismutase) (40–44). However, it has also been shown
that copper can decrease the stability of proteins. For example,
copper ions 1), promote transitions in the prion protein toward
less thermally stable conformations (45), 2), limit the revers-
ibility of thermal transitions of blue-copper proteins (46–48), and
3), bind specifically to nonnative states of b2-microglobulin,
resulting in a destabilization of the native state (49). Our work
presented here reveals that in the case of human CP, the
protein is thermally and kinetically stabilized by its copper co-
factors.
We have found that the thermal reaction of CP (both apo-
and holo- forms) is irreversible and involves two phases. An
irreversible two-step model was therefore used to analyze
thermal data collected by a set of different detection methods
(i.e., CD, fluorescence, and DSC). The similar parameters de-
rived from data collected by the different detection methods,
and for data collected with different scan rates, strongly sup-
port the validity of the assumed denaturation mechanism. Based
on the spectroscopic data (Fig. 2), the holo-intermediate spe-
cies has slightly perturbed secondary structure and exposes
50–70% of its tryptophans to the solvent (Fig. 3). The en-
thalpy data (Table 1) suggest that formation of the interme-
diate corresponds to about one-sixth of the overall enthalpy
change associated with the overall reaction (DH1 is about one-
sixth of total enthalpy change for holo-CP). These numbers
suggest that the intermediate has one or two domains (of the
six) unfolded. Because there is no significant increase in ANS
emission at the conditions favoring the thermal intermediate,
a partially folded species is disfavored over a species with most
domains fully folded and a few (or one) domains fully un-
folded.
The blue color experiments (Fig. 4) indicate that the holo-
intermediate has lost one oxidized type-1 copper, and the
activity experiments imply that the trinuclear cluster is intact
in the intermediate species. The oxidized type-1 copper that
is removed in the intermediate could be the one in either do-
main 4 or 6. We propose that it is more likely that it is the one
in domain 4, as disruption of the type-1 site in domain 6 (for
example, through domain unfolding) would likely also per-
turb the interface between domains 6 and 1 and therefore affect
the trinuclear copper site. It is also possible that the copper
loss in the first unfolding step corresponds to a small disrup-
tion of the metal site and that the affected protein domain (i.e.,
domain 4 or 6) remains folded. In analogy with the urea-
induced holo-CP intermediate observed at room temperature
that had lost two coppers (one oxidized and one reduced) (29),
we suggest that the reduced type-1 copper in domain 2 is also
absent in the thermal holointermediate of CP. We propose
that domain 2 is an unfolded domain in the intermediate; if so,
the parts of CP involved in oxidase activity are not affected
(which is in agreement with our observations) (Fig. 4).
The transition I/D is most likely accompanied by struc-
tural perturbation in all domains and loss of the trinuclear
copper cluster. Based on its CD spectrum, the final thermal
state,D, corresponds to a molten-globule species for both apo-
and holo-CP (Fig. 1). This species appears similar to the dead-
end molten globule detected on refolding attempts in urea from
the completely unfolded states of apo- and holo-CP at room
temperature (29). The starting state of apo-CP has an open
structure and no interactions between domains 1 and 6 (28).
Because the N/ I transition for apo-CP involves a similarly
low DH1 as in the case of holo-CP, it is likely that the same
domain is perturbed as in the holointermediate. In Fig. 5, a
tentative scheme for thermal perturbations of holo- and apo-
forms of CP that is based on our data is shown.
Inspection of the parameters from the fits (Table 1) reveals
that although the first transition (N to I) is only somewhat
stabilized in the holo- form (T1* increases by 4), the second
step (I to D) is much stabilized in the holo- form (T2* in-
creases by 18) as compared with the apo-form data. This im-
plies that although the trinuclear copper cluster (and thus the
interactions between domains 1 and 6) contributes to the ther-
mal stability of holo-CP, the type-1 coppers have almost no
such effect.
The activation/rate parameters obtained from the fits to the
DSC data enabled us to predict the time dependences of the
populations of gN, gI, and gD at 37C (and any other tem-
perature) for apo- and holo- forms of CP via Eq. 5 (Fig. 6). We
find that the native state of holo-CP is relatively unstable at
FIGURE 5 Tentative scheme for thermal unfolding of
holo- and apo- forms of CP based on our work (trapezoid
indicates intact domain, and circle molten-globule-like
domain). We propose that the first N-to-I transition
involves unfolding of one or two domains, perhaps domain
2 as shown here. For holo-CP, the N-to-I step also couples
to type-I copper release. One oxidized type-1 copper is lost
(the one in domain 4 is shown, but it could also be the one
in domain 6). If domain 2 is unfolded in I, it appears
reasonable that the reduced type-1 copper in this domain is
also lost (as shown here). This was previously concluded to
be the case for the urea-induced CP intermediate (29). The
last step involves destruction of the trinuclear copper
cluster and structural perturbations in all domains.
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physiological temperatures (i.e., 37C): it transforms to the
I state with a half-time of ;13.8 h at this temperature. The
I form of holo-CP is more kinetically stable: its half-life is
;17 days, pH 7, 37C. Because the (N/ I ) conversion occurs
on a biologically relevant time scale (i.e., hours at 37C), both
N and I forms of holo-CP may be present in vivo depending on
conditions and copper levels. Removal of copper results in an
apoprotein that has less kinetic stability at 37C. The rate of
disappearance of ‘‘native’’ apo-CP corresponds to a half-life
of 4.3 h (threefold faster than holo-CP). The intermediate
species of apo-CP disappears in 1.9 days (i.e., ninefold faster
than the holo- form). Notably, direct kinetic unfolding ex-
periments measured by fluorescence of apo- and holo-CP on
jumping to different final temperatures (between 42C and
60C) matched the values of k1 and k2 predicted from the DSC
parameters at each temperature (Supplementary Material). This
agreement between physical measurements and predictions
supports the conclusion that the assumed two-step mechanism
is appropriate and thus that the predicted kinetic parameters at
37C are valid.
CONCLUSIONS
In summary, we show that despite an apparent high thermal
stability (observed midpoint at 70–75C depending on condi-
tions), holo-CP with six intact coppers is a kinetically unstable
protein at physiological temperatures (i.e., at 37C, pH 7).
Within hours at this temperature, it converts to a much more
inert intermediate species that has lost one or two of the type-
1 copper ions. We propose that this intermediate may be present
in vivo under some conditions. Our earlier urea experiments
(pH 7, 20C) revealed a similar holo-I species that formed
reversibly on minor perturbations of the six-copper, fully
loaded state of CP (29). In the absence of all coppers, CP is
even more unstable; apo-CP is completely unfolded in ,2
days at 37C. The low kinetic stability of the apo- form of CP
may correlate with its rapid degradation in vivo in various
disease conditions (36).
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